Anika Therapeutics Inc.

32 Wiggins Avenue, 01730 Bedford, MA
USA
Telephone +1 781 457-9000
contact@anikatherapeutics.com

Home

Product Categories

Product categories

01 Electromedical Equipment / Medical Technology
01.05 Implants and protheses
01.05.03 Orthopaedic implants and prostheses

Orthopaedic implants and prostheses

One-Injection Combination Hyaluronic Acid and Steroid
A One-Injection OA Treatment
ORTHOVISC®-T: An Injectable Viscoelastic Sodium Hyaluronate

05 Commodities and Consumer Goods
05.15 Wound care equipment
05.15.07 Wound covering / skin substitutes

Wound covering / skin substitutes
Our products
One Injection Combination Hyaluronic Acid and Steroid

Product category: Orthopaedic implants and prostheses
One-Injection Combination Hyaluronic Acid and Steroid
CINGAL is the first and only approved combination viscosupplement formulated to provide the benefit of a cross-linked hyaluronic acid (HA) and a fast acting steroid to effectively treat the symptoms associated with osteoarthritis (OA).

CINGAL is a powerful, first-in-class treatment that combines the benefits of Anika’s proprietary cross-linked hyaluronic acid formulation of MONOVISC®, proven to deliver up to 6 months of relief of the symptoms of OA, with a well-established FDA-approved steroid to treat inflammation and provide additional short-term pain relief.1

CINGAL is Anika Therapeutics’ third-generation viscosupplementation product, adding to the Company’s strong product portfolio for the treatment of joint pain associated with OA.1 CINGAL extends the benefits of Anika’s proprietary HA formulation to a broader range of patients across the spectrum of osteoarthritis management.

Product category: Orthopaedic implants and prostheses
A One-Injection OA Treatment
MONOVISC is a single injection viscosupplement utilized to treat the joint pain caused by osteoarthritis. It is comprised of highly purified, partially cross-linked sodium hyaluronate (NaHA) in a phosphate buffered saline solution, and it is both biocompatible and resorbable.

With just one injection, MONOVISC may provide pain relief that lasts for up to 6 months.1

MONOVISC is the only non-animal sourced hyaluronic acid (HA) single injection treatment approved for use in the United States, and it delivers the maximum dose of HA (88mg) currently available in any single injection treatment.

Product category: Orthopaedic implants and prostheses
ORTHOVISC®-T: An Injectable Viscoelastic Sodium Hyaluronate
ORTHOVISC-T is an ultra-pure, high molecular weight injectable hyaluronic acid (HA) viscosupplement designed to relieve pain and restore function to tendons damaged by chronic tennis elbow. ORTHOVISC-T provides lubrication to promote tendon gliding, creating a beneficial healing environment.

ORTHOVISC-T is provided in a single-use syringe and is injected around the affected osteotendinous junction once a week for a total of two injections.

ad: contact information

About Us

Company details
We are Anika Therapeutics, a global medical technology company at the forefront of pain management, tissue regeneration and wound healing. We are committed to delivering innovative medical solutions that help patients feel better faster, look and feel younger and remain active. With over 30 million procedures performed in the past twenty-five years utilizing our proprietary technology, Anika is helping individuals all over the world return to life naturally.

ad: company

American Screening Corporation
Ameritek USA, Inc.
Amsino International Inc.
ANTICANCER INC. A/C Diagnostics
Apex-Desco Machine Company Corp.
Apple Rubber Products Inc.
Amsino International Inc.
Ameritek USA, Inc.
American Screening Corporation
American Preclinical Services
American Diagnostic Corporation

ANTICANCER INC. A/C Diagnostics
Apex-Desco Machine Company Corp.
Apple Rubber Products Inc.
Applied Biosensors, LLC
Argon Medical Devices, Inc.